Preventing Childhood Asthma Using Prophylactic House Dust Mite Allergen Immunotherapy

NCT05113394 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Awaiting funding

Conditions

Asthma
Allergy

Interventions

DRUG: HDM sublingual Immunotherapy
DRUG: Placebo

Sponsor

Boston Children's Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]